Basic Information
PharmAI makes early-stage drug discovery more efficient by increasing success rates while reducing costs. The company develops groundbreaking AI-driven software for analyzing 3D protein structures. This technology helps significantly shorten the timeline for discovering new therapeutic molecules.
PharmAI GmbH
Dresden,FreeStateofSaxony,Germany
15~50 people
January 01, 2019
hello@pharm.ai
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios